Shinnihon Pharmaceutical Co., Ltd. Shinnihon Pharmaceutical signed an official partner agreement with Rising Zephyr Fukuoka

Shinnihon Pharmaceutical Co., Ltd.
Shin Nihon Pharmaceutical Signs Official Partner Agreement with Rising Zephyr Fukuoka

Shinnihon Pharmaceutical Co., Ltd. (Headquarters: Fukuoka City, President and CEO: Takahiro Goto) and Rising Zephyr Fukuoka Co., Ltd. (Headquarters: Fukuoka City, President and CEO: Koichiro Furukawa), a professional basketball player in the B League, have announced that the 2022-2023 season We have signed an official partner contract with [Image 1d36592-203-fbe4cd4a8adae1746dd9-0.jpg&s3=36592-203-c586067c0e9d172306631d5c08924ad8-450x224.jpg
We have formulated the Shin Nihon Pharmaceutical Group Sustainability Basic Policy of “Limitless Future,” and as part of our sustainability activities, we are actively engaged in social contribution activities that revitalize local communities.
The wheelchair basketball team “Rising Zephyr Fukuoka Wheelchair,” which we have been supporting since 2020, gives us courage and excitement with the speed and powerful play unique to wheelchair basketball. We sympathize with the team’s efforts to popularize wheelchair basketball and actively engage in activities that lead to better understanding of people with disabilities, and we continue to support them.
[Image 2d36592-203-9ce504dd1bb92694435f-1.jpg&s3=36592-203-808afff55cb753389d26f3bdd18f29b3-500x316.jpg
*Photos were taken during the 2021-2022 season
As a company headquartered in Fukuoka Prefecture, we will continue to support companies that give dreams and energy to the local community. Agreement details
・Sponsorship of Rising Zephyr Fukuoka Wheelchair
・ Uniform (Rising Zephyr Fukuoka Wheelchair) Back / Contract period: October 1, 2022 to September 30, 2023
Details about this release:


Leave a Reply

Your email address will not be published.

%d bloggers like this: